FDA OKs Pfizer Drug for Rare, Fast-Killing Type of Leukemia – U.S. News & World Report

Tweet about this on TwitterPin on Pinterest0Share on Reddit0Share on Tumblr0Share on Google+0Share on StumbleUpon0Share on Facebook0Share on LinkedIn0Digg thisShare on Yummly0Share on VKFlattr the authorEmail this to someonePrint this page

U.S. News & World Report

FDA OKs Pfizer Drug for Rare, Fast-Killing Type of Leukemia
U.S. News & World Report
FDA approves new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed. Aug. 17, 2017, at 5:35 p.m.. MORE. LinkedIn · StumbleUpon · Google +; Cancel. FDA OKs Pfizer Drug for Rare, Fast-Killing Type of …
FDA approves Pfizer’s drug for rare blood cancerReuters
FDA Approves Inotuzumab Ozogamicin (Besponsa) for ALLMedscape
New Treatment Approved for Deadly Blood CancerHealthDay
News-Medical.net –MedPage Today –FDA.gov –Healio
all 31 news articles »

View original article
Author:

Powered by WPeMatico